These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22789622)

  • 1. Anti-HLA antibodies in regenerative medicine stem cell therapy.
    Charron D; Suberbielle-Boissel C; Tamouza R; Al-Daccak R
    Hum Immunol; 2012 Dec; 73(12):1287-94. PubMed ID: 22789622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-HLA antibodies in heart transplantation.
    Vasilescu ER; Ho EK; de la Torre L; Itescu S; Marboe C; Cortesini R; Suciu-Foca N; Mancini D
    Transpl Immunol; 2004 Jan; 12(2):177-83. PubMed ID: 14967316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-HLA immunogenetics in hematopoietic stem cell transplantation.
    Dickinson AM; Charron D
    Curr Opin Immunol; 2005 Oct; 17(5):517-25. PubMed ID: 16085403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome.
    Howie AJ
    Transplantation; 2007 Feb; 83(4):373-4. PubMed ID: 17318067
    [No Abstract]   [Full Text] [Related]  

  • 7. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding immunological rejection in regenerative medicine.
    Bolton EM; Bradley JA
    Regen Med; 2015; 10(3):287-304. PubMed ID: 25933238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.
    Nordlander A; Uhlin M; Ringdén O; Kumlien G; Hauzenberger D; Mattsson J
    Transpl Immunol; 2011 Sep; 25(2-3):153-8. PubMed ID: 21712089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for preventing immunologic rejection of transplanted human embryonic stem cells.
    Cabrera CM; Cobo F; Nieto A; Concha A
    Cytotherapy; 2006; 8(5):517-8. PubMed ID: 17050257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
    Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
    Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
    Sel S; Schlaf G; Schurat O; Altermann WW
    J Immunol Methods; 2012 Jul; 381(1-2):23-31. PubMed ID: 22561526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
    Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.
    Reinsmoen NL; Nelson K; Zeevi A
    Transpl Immunol; 2004; 13(1):63-71. PubMed ID: 15203130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.